Neurotransmitters and neuroreceptors in the lower urinary tract

Current Opinion in Obstetrics and Gynecology

Volumn 8, Issue 5, 1996, Pages 361-365

  Andersson, Karl Erik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ARGININE; CAPSAICIN; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROKININ A; NEUROKININ B; NEUROPEPTIDE; NEUROTRANSMITTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; RECEPTOR PROTEIN; RECEPTOR SUBTYPE; RESINIFERATOXIN; TACHYKININ; TACHYKININ RECEPTOR;

BLADDER DYSFUNCTION; DRUG DESIGN; EFFERENT NERVE; HUMAN; HYPERREFLEXIA; INTERSTITIAL CYSTITIS; INTRAVESICAL DRUG ADMINISTRATION; NERVE ENDING; NERVE FIBER C; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SENSORY NERVE; URGE INCONTINENCE;

EID: 0029851443     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199610000-00009     Document Type: Review

References (49)

1. Andersson K-E: Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 1993, 45:253-308.
2. 1A-adrenoceptors in the human female urethra by in-situ hybridization and quantitative autoradiography.
3. 3 receptors is shown.
4. 2 receptors is shown.
5. Andersson K-E: Recent advances in the physiology and pharmacology of the bladder. Current Opin Urol 1996, 6:196-199.
6. Maggi CA: Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Progr Neurobiol 1995, 45:1-98.
7. Maggi CA: The mammalian tachykinin receptors. Gen Pharmacol 1995, 26:911-944.
8. Giuliani S, Patacchini R, Barbanti G, Turini D, Rovero P, Quartara L, Giachetti A, Maggi CA: Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors. J Pharmacol Exp Ther 1993, 267:590-595.
9. Zeng X-P, Moore KH, Burcher E: Characterization of tachykinin NK-2 receptors in human urinary bladder. J Urol 1995, 153:1688-1692.
10. Zeng X-P, Burcher E: Tachykinin NK-2 receptors in child urinary bladder. J Urol 1996, 155:1104-1107.
11. de Groat WC, Kawatani M, Hisamitsu T, Cheng CL, Ma CP, Thor K, Steers W, Roppolo JR: Mechanisms underlying the recovery of urinary bladder function following spinal injury. J Auton Nerv Syst 1990, suppl 30:71-78.
12. Maggi CA, Barbanti G, Santicioli P, Beneforti P, Misuri D, Meli A, Turini D: Cystometric evidence that capsaicin-sensitivenerves modulate the afferent branch of micturition reflex in humans. J Urol 1989, 142:150-154.
13. Fowler CJ, Jewkes D, McDonald WI, Lynn B, de Groat WC: Intravesical capsaicin for neurogenic bladder dysfunction [Letter]. Lancet 1992, 339:1239.
14. Geirsson G, Fall M, Sullivan L: Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hyperreflexia. J Urol 1995, 154:1825-1829.
15. De Ridder D, Van Poppel H, Baert L: Management of intractable bladder hyperreflexia in multiple sclerosis by capsaicin instillation [Abstract]. J Urol 1996, 155:589.
16. Cruz F, Guimaraes M, Silva C, Rio ME, Coimbra A, Reis M: Intravesical capsaicin causes a long-lasting improvement in patients with bladder hyperactivity [Abstract]. J Urol 1996, 155:590.
17. Sedor JF, Chancellor MB, Rivas DA, Shupp-Byrne D, Hong R, de Groat WC: Intravesical capsaicin in neurologic impaired patients with detrusor hyperreflexia [Abstract] J Urol 1996, 155:592.
18. Ishizuka O, Mattiasson A, Andersson K-E: Urodynamic effects of intravesical resiniferatoxin and capsaicin in conscious rats with and without outflow obstruction. J Urol 1995, 154:611-616.
19. Ishizuka O, Igawa Y, Mattiasson A, Andersson K-E: Capsaicin-induced bladder hyperactivity in normal conscious rats. J Urol 1994, 152:525-530.
20. 1-adrenoceptors: consensus update. Pharmacol Rev 1995, 47:267-270.
21. 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience. Eur Urol 1996, 29:129-144.
22. 1-adrenoceptors and uroselectivity. Prostate 1996, in press.
23. Knepper SM, Buckner SA, Brune ME, DeBernardis JF, Meyer MD, Hancock AA: A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype. J Pharmacol Exp Ther 1995, 274:97-103.
24. 1-adrenoceptors. Eur J Pharmacol 1995, 291:327-334.
25. Wein AJ: Pharmacology of incontinence. Urol Clin North Am 1995, 22:557-577. A comprehensive review of current medical therapy of incontinence.
26. Eglen RM, Watson N: Selective muscarinic receptor agonists and antagonists. Pharmacol Toxicol 1996, 78:59-68. An up-to-date review of muscarinic receptor subtypes and of drugs for their selective stimulation and blockade.
27. 3-receptors coupled to inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells. J Urol 1995, 154:1241-1245.
28. Longhurst PA, Leggett RE, Briscoe JAK: Characterization of the functional muscarinic receptors in the rat urinary bladder. Br J Pharmacol 1995, 116:2279-2285.
29. Newgreen DT, Anderson CWP, Carter AJ, Naylor AM: Darifenacin - a novel bladder-selective agent for the treatment of urge incontinence. Neurourol Urodyn 1995, 14:95-96.
30. 3 antagonist. Pharmacol Res 1995, 31(suppl):54.
31. Yamamoto T, Koibuchi Y, Miura S, Sawada T, Ozaki R, Esumi K, Ohtsuka M: Effects of vamicamide on urinary bladder functions in conscious dog and rat models of urinary frequency. J Urol 1995, 154:2174-2178.
32. Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shinomura K: General pharmacology of the new antimuscarinic compound vamicamide. Arzeimittelforschung 1995, 45:1274-1284.
33. Watson N, Reddy H, Stefanich E, Eglen RM: Characterization of the interaction of zamifenacin at muscarinic receptors. Eur J Pharmacol 1995, 285:135-142.
34. Nilvebrant L, Glas G, Jönsson À, Sparf B: The in vitro pharmacological profile of tolterodine - a new agent for the treatment of urinary urge incontinence. Neurourol Urodyn 1994, 13:433-435.
35. Gillberg P-G, Modiri A-R, Sparf B: Tolterodine - a new agent with tissue effect selectivity for urinary bladder. Neurourol Urodyn 1994, 13:435-436.
36. Nilvebrant L, Andersson K-E, Gillberg P-G, Stahl M, Sparf B: Tolterodine - a new bladder selective antimuscarinic agent. Br J Pharmacol 1996 (in press).
37. Stahl MMS, Ekström B, Sparf B, Mattiasson A, Andersson K-E: Urodynamic and other effects of tolterodine: a novel antimuscarinic drug for the treatment of detrusor overactivity. Neurourol Urodyn 1995, 14:647-655.
38. Rand MJ, Li CG: Nitric oxide as a neurotransmitter in peripheral nerves: nature of transmission and mechanism of transmission. Annu Rev Physiol 1995, 57: 659-682. An up-to-date review of NO as a peripheral neurotransmitter.
39. Andersson K-E, Persson K: Nitric oxide synthase and the lower urinary tract: possible implications for physiology and pathophysiology. Scand J Urol Nephrol 1995, 29(suppl 175):43-53. An overview of the distribution of neurogenic NOS and functional and biochemical effects of NO in the lower urinary tract.
40. Burnett AL, Calvin DC, Chamness SL, Liu J-X, Dawson TM, Snyder SH: Lower urinary tract dysfunction in mice lacking neuronal nitric oxide synthase [Abstract]. J Urol 1996, 155:596. Important new observations on lower urinary tract morphology and function in mice lacking neuronal NOS.
41. Burnett AL: Nitric oxide control of lower genitourinary tract functions: a review. Urology 1995, 45:1071-1083.
42. Takeda M, Lepor H: Nitric oxide synthase in dog urethra: a histochemical and pharmacological analysis. Br J Pharmacol 1995, 116:2517-2523.
43. Bennett BC Kruse MN, Roppolo JR, Flood HD, Fraser M, de Groat WC: Neural control of urethral outlet activity in vivo: role of nitric oxide. J Urol 1995, 153:2004-2009. Demonstration of a reflex relaxation of the outflow region of female rats, mediated by NO, at the start of micturition.
44. Flood HD, Fraser MO, Yoshiyama M, Somogyi GT, de Groat WC: Nitric oxide (NO) mediated urethral relaxation is present in vivo in the female but not in the male rat [Abstract]. J Urol 1995, 153:135.
45. Alm P, Zygmunt PKE, Iselin C, Larsson B, Uvelius B, Werner S, Andersson K-E: Nitric oxide synthase-immunoreactive, adrenergic, cholinergic, and peptidergic nerves of the female rat urinary tract: a comparative study. J Auton Nerv Syst 1995, 56:105-114.
46. Persson K, Alm P, Johansson K, Larsson B, Andersson K-E: Co-existence of nitrergic, peptidergic and acetylcholine esterase-positive nerves in the pig lower urinary tract. J Auton Nerv Syst 1995, 52:115-236.
47. Ehrén I, Hammarström M, Adolfsson J, Wiklund NP: Induction of calcium-dependent nitric oxide synthase by sex hormones in the guinea-pig urinary bladder. Acta Physiol Scand 1995, 153:393-394.
48. Smith SS, Wheeler MA, Foster HE Jr, Weiss RM: Urinary nitric oxide synthase activity and cyclic GMP levels are decreased with interstitial cystitis and increased with urinary tract infections. J Urol 1996, 155:1432-1435. Demonstration of very low NO activity in the urine of patients with interstitial cystitis.
49. Ehrén I, Lundberg JON, Adolfsson J, Wiklund NP: Increased nitric oxide levels in the urinary bladder in patients with interstitial and irradiation cystitis. Stockholm: Karolinska Institute, 1996. Demonstration of increased levels of NO in air incubated in the bladder of patients with interstitial cystitis.